Impaired Viscosity of Gastric Secretion and Its Mucin Content as Potential Contributing Factors to the Development of Chronic Constipation

Digestive Diseases and Sciences

Volumn 59, Issue 11, 2014, Pages 2730-2734

  Castro Combs, Juan ^a   Garcia, Cesar J ^a   Majewski, Marek ^b   Wallner, Grzegorz ^b   Sarosiek, Jerzy ^a  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Chronic constipation; Gastric juice; Lubrication; Mucin; Viscosity

Indexed keywords

MUCIN; PENTAGASTRIN; STOMACH MUCIN;

ADULT; ARTICLE; CHRONIC CONSTIPATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SECRETION RATE; STOMACH JUICE; STOMACH SECRETION; VISCOSITY; AGED; CASE CONTROL STUDY; CHEMISTRY; CHRONIC DISEASE; CONSTIPATION; GASTROINTESTINAL MOTILITY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; CHRONIC DISEASE; CONSTIPATION; GASTRIC MUCINS; GASTROINTESTINAL MOTILITY; HUMANS; MIDDLE AGED; VISCOSITY; YOUNG ADULT;

EID: 84922392502     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3227-y     Document Type: Article

References (15)

1. Allen A, Flemstrom G, Garner A, Kivilaakso E. Gastroduodenal mucosal protection. Physiol Rev. 1993;73:823–857.
2. Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;347:1360–1368.
3. Wald A. Colonic transit and anorectal manometry in chronic idiopathic constipation. Arch Intern Med. 1986;146:1713–1716.
4. Wald A, Hinds JP, Caruana BJ. Psychological and physiological characteristics of patients with severe idiopathic constipation. Gastroenterology. 1989;97:932–937.
5. Mertz H, Naliboff B, Mayer EA. Symptoms and physiology in severe chronic constipation. Am J Gastroenterol. 1999;94:131–138.
6. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582–1591.
7. Higgins PD, Johanson JF. Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol. 2004;99:750–759.
8. Singh G, Lingala V, Wang H, et al. Use of health care resources and cost of care for adults with constipation. Clin Gastroenterol Hepatol. 2007;5:1053–1058.
9. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: relation of clinical subtypes to sociodemographic features. Am J Gastroenterol. 1999;94:3530–3540.
10. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–1491.
11. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130:1377–1390.
12. Jakab RL, Collaco AM, Ameen NA. Lubiprostone targets prostanoid signaling and promotes ion transporter trafficking, mucus exocytosis, and contractility. Dig Dis Sci. 2012;57:2826–2845.
13. De Lisle RC. Lubiprostone stimulates small intestinal mucin release. BMC Gastroenterol. 2012;12:156.
14. Majewski M, Sarosiek I, Wallner G, Sarosiek J. Significant increase of mucus and mucin secretion during administration of lubiprostone in patients with chronic constipation: its potential clinical implication [Abstract]. Gastroenterology. 2013;145:S-540.
15. Camilleri M, Bharucha AE, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol. 2006;290:942–947.